Long-term efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous transplantation (ASCT)

This article has no abstract
Epistemonikos ID: c22ed99ad2a8f3dfa1102c9150885332fe470450
First added on: Feb 11, 2025